Literature DB >> 16906355

Evaluation of acute antiapoptotic effects of Li+ in neuronal cell cultures.

M Yeste1, D Alvira, E Verdaguer, M Tajes, J Folch, V Rimbau, M Pallàs, A Camins.   

Abstract

Li(+) exerts protective effect against several neurotoxins in neuronal cell preparations. Here we examined the antiapoptotic effects of GSK3beta in cerebellar granule neurons (CGNs) in the presence of several neurotoxins. Acute treatment with Li(+) protected neurons against nocodazole and serum/potassium (S/K) deprivation, but were ineffective against kainic acid and MPP(+). Li(+) 5 mM also decreased caspase-3 activation induced by nocodazole and S/K deprivation as measured by Ac-DEVD-p-nitroaniline and the breakdown of alpha-spectrin. All the neurotoxins used in the present study activated GSK3beta, evaluated with a specific antibody phospho-GSK-3beta (Ser9) by Western-blot and immunocytochemistry and were always inhibited by Li(+) 5 mM. Our results implicate Li(+) in the regulation of apoptosis mediated by caspase activation (Type I). Furthermore inhibition of GSK3beta by acute treatment with Li(+) 5 mM is not an indicator of neuroprotection. The acute antiapoptotic function of Li(+) is discussed in terms of its inhibition of Type I pathway, the intrinsic (mitochondrial) apoptotic pathway in cerebellar granule cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906355     DOI: 10.1007/s00702-006-0557-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  55 in total

Review 1.  Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

Authors:  Todd D Gould; Carlos A Zarate; Husseini K Manji
Journal:  J Clin Psychiatry       Date:  2004-01       Impact factor: 4.384

Review 2.  GSK3 inhibitors: development and therapeutic potential.

Authors:  Philip Cohen; Michel Goedert
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

3.  HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity.

Authors:  S B Maggirwar; N Tong; S Ramirez; H A Gelbard; S Dewhurst
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

4.  Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells.

Authors:  R Lu; L Song; R S Jope
Journal:  Neuroreport       Date:  1999-04-06       Impact factor: 1.837

5.  Kainic acid-induced neuronal cell death in cerebellar granule cells is not prevented by caspase inhibitors.

Authors:  Ester Verdaguer; Elvira García-Jordà; Andrés Jiménez; Alessandra Stranges; Francesc X Sureda; Anna M Canudas; Elena Escubedo; Jordi Camarasa; Mercè Pallàs; Antoni Camins
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

6.  Overexpression of neuronal pentraxin 1 is involved in neuronal death evoked by low K(+) in cerebellar granule cells.

Authors:  N DeGregorio-Rocasolano; T Gasull; R Trullas
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A.

Authors:  Alfonso Mora; Guadalupe Sabio; Ana María Risco; Ana Cuenda; Juan C Alonso; Germán Soler; Francisco Centeno
Journal:  Cell Signal       Date:  2002-06       Impact factor: 4.315

8.  Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo.

Authors:  Sharon Goodenough; Sabine Conrad; Thomas Skutella; Christian Behl
Journal:  Brain Res       Date:  2004-11-05       Impact factor: 3.252

9.  Antiapoptotic effects of roscovitine in cerebellar granule cells deprived of serum and potassium: a cell cycle-related mechanism.

Authors:  Ester Verdaguer; Elvira G Jordá; Anna M Canudas; Andrés Jiménez; David Pubill; Elena Escubedo; Jordi Camarasa; Mercè Pallàs; Antoni Camins
Journal:  Neurochem Int       Date:  2004-03       Impact factor: 3.921

10.  Different dependence of lithium and valproate on PI3K/PKB pathway.

Authors:  Alfonso Mora; Guadalupe Sabio; Juan C Alonso; Germán Soler; Francisco Centeno
Journal:  Bipolar Disord       Date:  2002-06       Impact factor: 6.744

View more
  5 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis.

Authors:  Chiara Terracciano; Anna Nogalska; W King Engel; Valerie Askanas
Journal:  J Neurochem       Date:  2009-10-29       Impact factor: 5.372

3.  Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.

Authors:  M S Breen; C H White; T Shekhtman; K Lin; D Looney; C H Woelk; J R Kelsoe
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

Review 4.  The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

5.  Potential protective effects of autophagy activated in MPP+ treated astrocytes.

Authors:  Cunzhou Shen; Wenbiao Xian; Hongyan Zhou; Ling Chen; Zhong Pei
Journal:  Exp Ther Med       Date:  2016-09-21       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.